Bendectin and Birth Defects : : The Challenges of Mass Toxic Substances Litigation / / Michael D. Green.
Benedictin was prescribed to more than thirty-five million American women from its introduction in 1956 until 1983, when it was withdrawn from the market. The drug's manufacturer, Merrill Dow Pharmaceuticals, a major U.S. pharmaceutical firm, joined a list of other companies whose product liabi...
Saved in:
Superior document: | Title is part of eBook package: De Gruyter University of Pennsylvania Press Package Archive 1898-1999 |
---|---|
VerfasserIn: | |
Place / Publishing House: | Philadelphia : : University of Pennsylvania Press, , [2016] ©1996 |
Year of Publication: | 2016 |
Language: | English |
Online Access: | |
Physical Description: | 1 online resource (384 p.) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Asbestos litigation / Stephen J. Carroll ... [et al.].
Published: (2005.) -
Asbestos litigation / Stephen J. Carroll ... [et al.].
Published: (2005.) -
Dust-up : asbestos litigation and the failure of commonsense policy reform / / Jeb Barnes.
by: Barnes, Jeb.
Published: (c2011.) -
Economic effects of product liability and other litigation involving the safety and effectiveness of pharmaceuticals / Steven Garber.
by: Garber, Steven.
Published: (2013.) -
Economic effects of product liability and other litigation involving the safety and effectiveness of pharmaceuticals / Steven Garber.
by: Garber, Steven.
Published: (2013.)